Infant Bacterial Therapeutics
Annual Report 2022

Loading PDF...

More annual reports from Infant Bacterial Therapeutics:

2023 Report
2022 Report
2021 Report
2020 Report
2019 Report

Share your feedback:


Peers and competitors of Infant Bacterial Therapeutics:

KRM22
Clime Capital Limited
T. Rowe Price Group
The Manitowoc Company
Blue Sky Alternative